Associated Papers
Structural basis of the fanconi anemia-associated mutations within the FANCA and FANCG complex.
Jeong E et al.
Nucleic Acids Research, 2020
Fanconi anemia A is a nucleocytoplasmic shuttling molecule required for gonadotropin-releasing hormone (GnRH) transduction of the GnRH receptor.
Larder R et al.
Endocrinology, 2006
The Fanconi anemia gene network is conserved from zebrafish to human.
Titus TA et al.
Gene, 2006
Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
Adachi D et al.
Human Molecular Genetics, 2002
A cytoplasmic serine protein kinase binds and may regulate the Fanconi anemia protein FANCA.
Yagasaki H et al.
Blood, 2001
Functional analysis of patient-derived mutations in the Fanconi anemia gene, FANCG/XRCC9.
Nakanishi K et al.
Experimental Hematology, 2001
The emerging genetic and molecular basis of Fanconi anaemia.
Joenje H et al.
Nature Reviews. Genetics, 2001
The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG.
de Winter JP et al.
Human Molecular Genetics, 2000
High frequency of large intragenic deletions in the Fanconi anemia group A gene.
Morgan NV et al.
American Journal of Human Genetics, 1999
A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA.
Waisfisz Q et al.
Proceedings of the National Academy of Sciences of the United States of America, 1999
Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex.
Garcia-Higuera I et al.
Molecular and Cellular Biology, 1999
A patient-derived mutant form of the Fanconi anemia protein, FANCA, is defective in nuclear accumulation.
Kupfer G et al.
Experimental Hematology, 1999
Select a paper to view details